Avenue therapeutics to present at h.c. wainwright 25th annual global investment conference

Miami, sept. 05, 2023 (globe newswire) -- avenue therapeutics, inc. (nasdaq: atxi) (“avenue” or the “company”), a specialty pharmaceutical company focused on the development and commercialization of therapies for the treatment of neurologic diseases, today announced that alexandra maclean, m.d., chief executive officer, will present a corporate update at the h.c. wainwright 25th annual global investment conference scheduled to take place september 11-13, 2023. the presentation will be available for on-demand viewing starting monday, september 11, 2023 at 7:00 a.m. et.
ATXI Ratings Summary
ATXI Quant Ranking